APN - Ticker AI Digest

Applied Nutrition Plc 📰 1
Desk Snapshot GO VIP Login
Important AI Risk Notice

Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.

Not investment advice. Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate. Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only. Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally. Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Applied Nutrition Plc in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
APN Data 2025-04-07 Preview Mode
Core Deck
Deep Dive Modules

Digested News

Today's Catalysts (APN) 1
APN 06:01
Applied Nutrition Plc
Interim Results
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
Applied Nutrition plc, a leading sports nutrition, health, and wellness brand, announces its interim results for the six months ended January 31, 2025 ("H1 FY25"). The company reports strong financial performance with H1 FY25 revenue of £47.6 million, exceeding IPO guidance. The UK and Europe delivered exceptional year-on-year growth, while International sales declined due to brought forward orders in the Middle East. The company maintains a robust gross margin despite rising whey prices. Adjusted EBITDA was £13.8m with a margin of c.29%, and free cash flow conversion was strong at 64.5%.
The company highlights significant progress in delivering its global growth strategy, with new customer wins, expansion into new geographies, and successful new product launches. The factory extension completed in August increased revenue capacity to £160 million.
Current trading remains strong, with record revenues in March, and the company reiterates its full-year outlook. The relatively low exposure to whey protein and careful procurement are expected to mitigate the impact of higher whey prices on margins. The partnership with Holland & Barrett and new US retailer listings underpin more than half of FY26 forecast revenue growth.
The companys CEO, Thomas Ryder, expresses pride in the maiden results and highlights the companys ambition, growth, and strategic progress. He attributes the strong foundation set for the second half to the teams relentless enthusiasm, commitment, and delivery.
<>Applied Nutrition Financials and Debt Comparison

Applied Nutrition Financials and Debt Comparison

MetricH1 FY25H1 FY24Change
Revenue£47.6 million£45.4 million4.8% increase
Gross Profit£22.3 million£22.7 million1.8% decrease
Adjusted EBITDA£13.8 million£16.4 million15.9% decrease
Adjusted Basic and Diluted EPS4.2p4.9p14.3% decrease
Free Cash Flow (after tax)£8.9 million£6.7 million32.8% increase
Free Cash Flow Conversion (after tax)64.5%40.9%57.7% increase

Debt Comparison

No specific debt figures were mentioned in the given text.

AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 2
APN 06:01
Applied Nutrition Plc
Interim Results
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
Applied Nutrition plc, a leading sports nutrition, health, and wellness brand, announces its interim results for the six months ended January 31, 2025 ("H1 FY25"). The company reports strong financial performance with H1 FY25 revenue of £47.6 million, exceeding IPO guidance. The UK and Europe delivered exceptional year-on-year growth, while International sales declined due to brought forward orders in the Middle East. The company maintains a robust gross margin despite rising whey prices. Adjusted EBITDA was £13.8m with a margin of c.29%, and free cash flow conversion was strong at 64.5%.
The company highlights significant progress in delivering its global growth strategy, with new customer wins, expansion into new geographies, and successful new product launches. The factory extension completed in August increased revenue capacity to £160 million.
Current trading remains strong, with record revenues in March, and the company reiterates its full-year outlook. The relatively low exposure to whey protein and careful procurement are expected to mitigate the impact of higher whey prices on margins. The partnership with Holland & Barrett and new US retailer listings underpin more than half of FY26 forecast revenue growth.
The companys CEO, Thomas Ryder, expresses pride in the maiden results and highlights the companys ambition, growth, and strategic progress. He attributes the strong foundation set for the second half to the teams relentless enthusiasm, commitment, and delivery.
<>Applied Nutrition Financials and Debt Comparison

Applied Nutrition Financials and Debt Comparison

MetricH1 FY25H1 FY24Change
Revenue£47.6 million£45.4 million4.8% increase
Gross Profit£22.3 million£22.7 million1.8% decrease
Adjusted EBITDA£13.8 million£16.4 million15.9% decrease
Adjusted Basic and Diluted EPS4.2p4.9p14.3% decrease
Free Cash Flow (after tax)£8.9 million£6.7 million32.8% increase
Free Cash Flow Conversion (after tax)64.5%40.9%57.7% increase

Debt Comparison

No specific debt figures were mentioned in the given text.

APN 07:01
Applied Nutrition Plc
Notice of Results and Presentations
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 1
APN 08:01
Applied Nutrition Plc
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 4
APN 06:01
Applied Nutrition Plc
Interim Results
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
Applied Nutrition plc, a leading sports nutrition, health, and wellness brand, announces its interim results for the six months ended January 31, 2025 ("H1 FY25"). The company reports strong financial performance with H1 FY25 revenue of £47.6 million, exceeding IPO guidance. The UK and Europe delivered exceptional year-on-year growth, while International sales declined due to brought forward orders in the Middle East. The company maintains a robust gross margin despite rising whey prices. Adjusted EBITDA was £13.8m with a margin of c.29%, and free cash flow conversion was strong at 64.5%.
The company highlights significant progress in delivering its global growth strategy, with new customer wins, expansion into new geographies, and successful new product launches. The factory extension completed in August increased revenue capacity to £160 million.
Current trading remains strong, with record revenues in March, and the company reiterates its full-year outlook. The relatively low exposure to whey protein and careful procurement are expected to mitigate the impact of higher whey prices on margins. The partnership with Holland & Barrett and new US retailer listings underpin more than half of FY26 forecast revenue growth.
The companys CEO, Thomas Ryder, expresses pride in the maiden results and highlights the companys ambition, growth, and strategic progress. He attributes the strong foundation set for the second half to the teams relentless enthusiasm, commitment, and delivery.
<>Applied Nutrition Financials and Debt Comparison

Applied Nutrition Financials and Debt Comparison

MetricH1 FY25H1 FY24Change
Revenue£47.6 million£45.4 million4.8% increase
Gross Profit£22.3 million£22.7 million1.8% decrease
Adjusted EBITDA£13.8 million£16.4 million15.9% decrease
Adjusted Basic and Diluted EPS4.2p4.9p14.3% decrease
Free Cash Flow (after tax)£8.9 million£6.7 million32.8% increase
Free Cash Flow Conversion (after tax)64.5%40.9%57.7% increase

Debt Comparison

No specific debt figures were mentioned in the given text.

APN 08:01
Applied Nutrition Plc
Holding(s) in Company
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
APN 07:01
Applied Nutrition Plc
Notice of Results and Presentations
APN 06:01
Applied Nutrition Plc
Key customer expansion underpinning future growth

Today's AI

Today's AI Starts With News

1 live catalyst is opening Today’s AI for APN.

Start with the live headline tape first. Today’s AI findings sit next, and the AI Blend stack drops lower once the news context is framed. Financial Forecastist now feeds the blend too.
Live Tape Data 2025-04-07 Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
1 Today
Front Of Desk
Applied Nutrition Plc has fresh news flow live now, so Today’s AI is leading with the tape before the blended signal stack below.
Single-Ticker Today's AI
APN signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.

This is the ticker-specific Today’s AI desk for Applied Nutrition Plc. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI + Financial Blend Buy / Sell Trigger Engine Today's AI Findings
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full APN Today’s AI cockpit.

Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for APN on 2025-04-07.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
543.7M
Enterprise Value
-
Public Float
44.8
Broker Target
290.857
Shares Out
250.0M
Long Interest
100
Short Interest
0
Exchange
-
Currency Code
-
ISIN
-
Market
-
Sector
Unknown
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

News And Alerts First

1 live alert now opens the financials desk for APN.

Start with the headline flow and alert tape first. Then drop straight into Financial Forecastist below for the revenue path, EPS shape, cash pressure and balance-sheet read while the catalyst context is still hot.
Live Alerts Data 2025-04-07 Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
1 Alerts
Front Of Desk
Applied Nutrition Plc has fresh filing flow live now, so the tape is framing the revenue, leverage and valuation story below.
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
-
Earnings Date
-
Net Debt
-15.5M
Cash
18.5M
EPS
0.08
Net Income
21.1M
Revenue
134.0M
Enterprise Value
-
Trailing PE
27.1875
Forward PE
17.1233
Price Sales TTM
4.0578
Price Book MRQ
7.8125
EV Revenue
4.8595
EV EBITDA
17.5236
Financial Forecastist

Mixed financial engine

Revenue is accelerating +25.2% against the prior comparable period. Net margin is stable by 0.2 pts. Net debt is building +50.3%.

Revenue +25.2% Net Income +26.2% FCF +3.8% Current Ratio 3.46x Forward Rev 139.6M
Mixed
Quarter Revenue
74.5M
+25.2%
vs prior comparable quarter
Net Margin
+20.7%
+0.2 pts
profitability pulse
Free Cash Flow
8.3M
+3.8%
cash conversion
Net Debt / EBITDA
-1.1x
+50.3%
lower is cleaner
Revenue Engine

Latest quarter printed 74.5M with the top line pushing higher against the last comparable period.

Profit Stack

Net income landed at 15.4M and the margin profile is stable. That usually tells us whether operating leverage is finally kicking in.

Balance-Sheet Pressure

Cash sits near 26.4M while net debt is -23.3M. The leverage stack is moving the wrong way.

Quarterly Revenue Runway

Actual revenue bars, consensus revenue where available, plus the terminal model path.

Profit And Cash Conversion

Net income and free cash flow moving together is usually what separates genuine improvement from noise.

Balance-Sheet Pressure

Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.

Annual Power Curve

Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q2 2026
Model
90.2M
Revenue Path
-
EPS / Earnings
Growth cue -
Q3 2026
Model
106.1M
Revenue Path
-
EPS / Earnings
Growth cue -
Q4 2026
Model
122.5M
Revenue Path
-
EPS / Earnings
Growth cue -
Q1 2027
Model
139.6M
Revenue Path
-
EPS / Earnings
Growth cue -
FY 2026
Consensus
140.3M
Revenue Path
0.11
EPS / Earnings
Growth cue +0.3%
FY 2027
Consensus
155.2M
Revenue Path
0.13
EPS / Earnings
Growth cue +0.1%

Quarterly Statement Tape

Last 6 Quarters
Period Revenue Net Income FCF Net Debt
Q1 2026 74.5M 15.4M 8.3M -23.3M
Q3 2025 59.5M 12.2M 8.0M -15.5M
Q1 2025 47.6M 8.9M 7.2M -9.2M
Q3 2024 - - - -16.9M

Annual Financial Power

Last 5 Years
Period Revenue Net Income EBITDA FCF
FY 2025 107.1M 21.1M 29.7M 15.2M
FY 2024 86.2M 18.7M 25.4M 6.3M
FY 2023 60.8M 13.8M 18.6M 7.6M
FY 2022 35.0M 8.2M 10.4M 6.2M

Structure DNA

Market Structure DNA has not been loaded for this ticker yet. Once the A15 loader runs, this desk will light up with regime labels, ownership lock, dividend cadence, and structure charts.

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
11.0395
Institutions As Of
2026-04-28
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
0
Sale Director Dealing
0
Purchase TR1
18
Sale TR1
25
Broker Coverage Rows
8
Institution Holders Tracked
4
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

News And Alerts First

The alert tape opens the door for APN, and AI Charts sits just below.

Start with the headline flow and live catalyst tape first. Then move straight into AI Charts below for price reaction, AI targets, chart structure and catalyst beacons while the news context is still hot.
Live Tape Data 2025-04-07 AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
1 Today
Catalyst Pulse
Applied Nutrition Plc has fresh news flow live now, so the tape is framing the chart workspace below.
AI Charts Studio
APN Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2025-04-07 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
Desk Snapshot Member Login
Indicators0
Technicals0
AI Forecast 114.79%
RSI Gauge
Price Change
AI Forecast